Alvotech (ALVO)
13.49
-0.01
(-0.07%)
USD |
NASDAQ |
May 17, 16:00
13.49
0.00 (0.00%)
After-Hours: 20:00
Alvotech Enterprise Value: 4.723B for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 4.723B |
| May 16, 2024 | 4.723B |
| May 15, 2024 | 4.681B |
| May 14, 2024 | 4.681B |
| May 13, 2024 | 4.664B |
| May 10, 2024 | 4.687B |
| May 09, 2024 | 4.751B |
| May 08, 2024 | 4.734B |
| May 07, 2024 | 4.824B |
| May 06, 2024 | 4.969B |
| May 03, 2024 | 4.975B |
| May 02, 2024 | 5.006B |
| May 01, 2024 | 4.997B |
| April 30, 2024 | 5.003B |
| April 29, 2024 | 4.924B |
| April 26, 2024 | 4.905B |
| April 25, 2024 | 4.765B |
| April 24, 2024 | 4.734B |
| April 23, 2024 | 4.695B |
| April 22, 2024 | 4.676B |
| April 19, 2024 | 4.645B |
| April 18, 2024 | 4.553B |
| April 17, 2024 | 4.527B |
| April 16, 2024 | 4.508B |
| April 15, 2024 | 4.444B |
| Date | Value |
|---|---|
| April 12, 2024 | 4.371B |
| April 11, 2024 | 4.262B |
| April 10, 2024 | 4.270B |
| April 09, 2024 | 4.284B |
| April 08, 2024 | 4.307B |
| April 05, 2024 | 4.309B |
| April 04, 2024 | 4.212B |
| April 03, 2024 | 4.217B |
| April 02, 2024 | 4.136B |
| April 01, 2024 | 4.435B |
| March 28, 2024 | 4.365B |
| March 27, 2024 | 4.494B |
| March 26, 2024 | 4.444B |
| March 25, 2024 | 4.659B |
| March 22, 2024 | 5.129B |
| March 21, 2024 | 4.970B |
| March 20, 2024 | 5.013B |
| March 19, 2024 | 5.015B |
| March 18, 2024 | 4.959B |
| March 15, 2024 | 5.034B |
| March 14, 2024 | 5.039B |
| March 13, 2024 | 5.055B |
| March 12, 2024 | 5.037B |
| March 11, 2024 | 5.066B |
| March 08, 2024 | 5.111B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.806B
Minimum
Jul 15 2022
5.557B
Maximum
Feb 26 2024
3.378B
Average
3.249B
Median
Enterprise Value Benchmarks
| AbbVie Inc | 349.85B |
| Teva Pharmaceutical Industries Ltd | 35.37B |
| Moolec Science SA | 51.09M |
| Procaps Group SA | 563.27M |
| NeuroMetrix Inc | -9.964M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -276.56M |
| Revenue (Quarterly) | 53.39M |
| Total Expenses (Quarterly) | 130.54M |
| EPS Diluted (Quarterly) | -1.22 |
| Gross Profit Margin (Quarterly) | -5.67% |
| Profit Margin (Quarterly) | -518.0% |
| Earnings Yield | -18.00% |
| Normalized Earnings Yield | -13.63 |